Matinas BioPharma Holdings, Inc. (MTNB)
0.182
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.1816
0.00 (0.00%)
Pre-Market: 09:16
Matinas BioPharma Holdings Debt to Equity Ratio : 0.0033 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0033 |
| March 31, 2026 | 0.3934 |
| December 31, 2025 | 0.2803 |
| September 30, 2025 | 0.3613 |
| June 30, 2025 | 0.3296 |
| March 31, 2025 | 0.4329 |
| December 31, 2024 | 0.3813 |
| September 30, 2024 | 0.1946 |
| June 30, 2024 | 0.1697 |
| March 31, 2024 | 0.2335 |
| December 31, 2023 | 0.1848 |
| September 30, 2023 | 0.1602 |
| June 30, 2023 | 0.1384 |
| March 31, 2023 | 0.1223 |
| December 31, 2022 | 0.1126 |
| September 30, 2022 | 0.1096 |
| June 30, 2022 | 0.1035 |
| March 31, 2022 | 0.0958 |
| December 31, 2021 | 0.0896 |
| September 30, 2021 | 0.083 |
| June 30, 2021 | 0.0558 |
| March 31, 2021 | 0.0545 |
| December 31, 2020 | 0.0588 |
| September 30, 2020 | 0.0568 |
| June 30, 2020 | 0.0548 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.053 |
| December 31, 2019 | 0.1279 |
| September 30, 2019 | 0.1144 |
| June 30, 2019 | 0.1103 |
| March 31, 2019 | 0.108 |
| December 31, 2018 | 0.0242 |
| September 30, 2018 | 0.051 |
| June 30, 2018 | 0.0124 |
| March 31, 2018 | 0.0249 |
| December 31, 2017 | 0.0248 |
| September 30, 2017 | 0.0285 |
| June 30, 2017 | 0.0046 |
| March 31, 2017 | 0.0038 |
| December 31, 2016 | 0.0202 |
| September 30, 2016 | 0.0249 |
| June 30, 2016 | 0.0101 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.0019 |
| September 30, 2015 | 0.0047 |
| June 30, 2015 | 0.0051 |
| March 31, 2015 | 0.0016 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.412M |
| Total Liabilities (Quarterly) | 1.612M |
| Shareholders Equity (Quarterly) | 1.80M |
| Current Ratio | 0.8467 |
| Net Debt Paydown Yield | 13.81% |